Kasper Peter, Oliver Gerry, Lima Beatriz Silva, Singer Thomas, Tweats David
Federal Institute for Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, D-53175 Bonn, Germany.
Pharmacogenomics. 2005 Mar;6(2):181-4. doi: 10.1517/14622416.6.2.181.
A workshop was held on October 26-27, 2004, in Bonn, Germany, to discuss the potential use of omic technologies for regulatory non-clinical safety testing of pharmaceuticals. The meeting was hosted by the European Federation of Pharmaceutical Industries and Associations (EFPIA). The workshop was held in conjunction with the 6th European preclinical assessors meeting, which was organized in Bonn by the German Federal Institute for Drugs and Medical Devices (BfArM) and the Safety Working Party (SWP) of the Committee for Medicinal Products for Human Use (CHMP). Approximately 100 scientists, roughly half from the European pharmaceutical industry and half from European regulatory authorities, attended the workshop. The authors of this report constitute the organizing committee members.
2004年10月26日至27日,一场研讨会在德国波恩举行,旨在探讨组学技术在药品监管非临床安全性测试中的潜在应用。该会议由欧洲制药工业协会联合会(EFPIA)主办。此次研讨会与第六届欧洲临床前评估员会议同期举行,后者由德国联邦药品和医疗器械研究所(BfArM)以及人用药品委员会(CHMP)的安全工作组(SWP)在波恩组织。约100名科学家参加了此次研讨会,其中约一半来自欧洲制药行业,另一半来自欧洲监管机构。本报告的作者为组织委员会成员。